Jump to content

Use of minimal disseminated disease and immunity to NPM-ALK antigen to stratify ALK-positive ALCL patients with different prognosis. (Q39566627)

From Wikidata

scientific article published on 18 July 2012

Language	Label	Description	Also known as
default for all languages	No label defined
English	Use of minimal disseminated disease and immunity to NPM-ALK antigen to stratify ALK-positive ALCL patients with different prognosis.	scientific article published on 18 July 2012

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22907048%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Use of minimal disseminated disease and immunity to NPM-ALK antigen to stratify ALK-positive ALCL patients with different prognosis (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22907048%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22907048%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

author name string

C Damm-Welk

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22907048%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

M Pillon

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22907048%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

M Zimmermann

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22907048%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

G Franceschetto

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22907048%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

K Pulford

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22907048%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

A Reiter

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22907048%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

A Rosolen

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22907048%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

W Woessmann

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22907048%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

publication date

18 July 2012

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22907048%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

language of work or name

0 references

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22907048%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

27

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22907048%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22907048%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

416-422

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22907048%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

The impact of age and gender on biology, clinical features and treatment outcome of non-Hodgkin lymphoma in childhood and adolescence

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.205

21 January 2018

Short-pulse B-non-Hodgkin lymphoma-type chemotherapy is efficacious treatment for pediatric anaplastic large cell lymphoma: a report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.205

21 January 2018

Single-drug vinblastine as salvage treatment for refractory or relapsed anaplastic large-cell lymphoma: a report from the French Society of Pediatric Oncology

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.205

21 January 2018

Prognostic factors in childhood anaplastic large cell lymphoma: results of a large European intergroup study

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.205

21 January 2018

Prognostic impact of morphologic and phenotypic features of childhood ALK-positive anaplastic large-cell lymphoma: results of the ALCL99 study

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.205

21 January 2018

Impact of the methotrexate administration dose on the need for intrathecal treatment in children and adolescents with anaplastic large-cell lymphoma: results of a randomized trial of the EICNHL Group

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.205

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.205

21 January 2018

Gene-expression profiling of systemic anaplastic large-cell lymphoma reveals differences based on ALK status and two distinct morphologic ALK+ subtypes

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.205

21 January 2018

CD4 T-helper responses to the anaplastic lymphoma kinase (ALK) protein in patients with ALK-positive anaplastic large-cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.205

21 January 2018

Oncogenic kinase NPM/ALK induces through STAT3 expression of immunosuppressive protein CD274 (PD-L1, B7-H1).

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.205

21 January 2018

Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the Leukemia and Lymphoma Mol

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.205

21 January 2018

The 2008 WHO lymphoma classification

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.205

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence and clinical implications of bone marrow involvement in pediatric anaplastic large cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.205

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic significance of circulating tumor cells in bone marrow or peripheral blood as detected by qualitative and quantitative PCR in pediatric NPM-ALK-positive anaplastic large-cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.205

7 January 2021

based on heuristic

inferred from DOI database lookup

Kinetics of humoral response to ALK and its relationship with minimal residual disease in pediatric ALCL

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.205

7 January 2021

based on heuristic

inferred from DOI database lookup

Correlation of the autoantibody response to the ALK oncoantigen in pediatric anaplastic lymphoma kinase–positive anaplastic large cell lymphoma with tumor dissemination and relapse risk

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.205

7 January 2021

based on heuristic

inferred from DOI database lookup

Results of AIEOP LNH-97 protocol for the treatment of anaplastic large cell lymphoma of childhood

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.205

7 January 2021

based on heuristic

inferred from DOI database lookup

Germline mutations of the perforin gene are a frequent occurrence in childhood anaplastic large cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.205

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/LEU.2012.205

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22907048%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22907048%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39566627&oldid=2427188773"